April 2020

  /    /  April (Page 3)

An appeals court has upheld the validity of ChromaDex’s patent rights to isolated nicotinamide riboside (NR), according to a press release issued by the company Tuesday. The challenge came from competitor Elysium Health. The patent rights are held by the Trustees of

This article is reprinted with permission from UCI Beall Applied Innovation. Written by Jackie Connor. Photo by Daniel Xu. Becoming an investor requires curiosity, passion and a lot of due diligence – and that is what Xandra Laskowski has acquired throughout

You don't have permission to register